Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.

LLY's post-market drop offers investment potential with robust R&D, capex strategies, and strong cash flow, positioning it ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

U.S. stocks performed positively again this week as investors assessed a flood of corporate earnings and the latest news regarding tariffs and trade talks.